News
Start-up Neuron-D using innovative technology of IPF
The Dresden-based start-up Neuron-D GmbH is developing a high-throughput system for testing drug candidates to treat neurodegenerative diseases on the basis of a license agreement with the German Center for Neurodegenerative Diseases (DZNE) and the Leibniz Institute of Polymer Research Dresden (IPF).
The technology is based on a method jointly developed by the DZNE and IPF for the production of 3D cell cultures. This makes it possible to reproduce key features of neurons in the human brain and the disease process associated with neurodegeneration.
The method was based on the hydrogel technology developed at the IPF by Prof. Dr. Carsten Werner and Dr. Uwe Freudenberg.
18.03.2021